Hybrid coronary revascularization
Hybrid coronary revascularization (HCR) is a cardiac surgical procedure that combines traditional coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI). This procedure is typically used for patients with multivessel coronary artery disease who are not suitable candidates for traditional CABG or PCI alone.
History
The concept of hybrid coronary revascularization was first introduced in the late 1990s. The procedure was developed as a less invasive alternative to traditional CABG, with the goal of reducing surgical morbidity and improving patient outcomes.
Procedure
Hybrid coronary revascularization typically involves a two-step process. The first step is a minimally invasive direct coronary artery bypass (MIDCAB) procedure, in which the surgeon bypasses the blocked coronary artery using a graft from the patient's own chest wall. The second step is a PCI procedure, in which a stent is inserted into the blocked artery to help keep it open.
Advantages
The main advantage of hybrid coronary revascularization is that it combines the benefits of both CABG and PCI. The CABG component of the procedure allows for complete revascularization of the heart, while the PCI component allows for a less invasive approach and faster recovery time.
Risks and Complications
As with any surgical procedure, hybrid coronary revascularization carries certain risks and potential complications. These may include bleeding, infection, stroke, and heart attack. However, the risk of these complications is generally lower with HCR than with traditional CABG or PCI alone.
Future Directions
While hybrid coronary revascularization is currently used in a select group of patients, ongoing research and technological advancements may expand its use in the future. Studies are currently underway to further evaluate the safety and efficacy of this procedure, and to compare it with traditional CABG and PCI.
This article is a cardiovascular system stub. You can help WikiMD by expanding it!
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD